# US 2026/0232838 A1 · Synthetic melanin nanoparticles for protection of cell-free reactions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0232838 A1
- Document ID: US20260232838A1
- Status: Published application
- Kind: A1
- Application number: 19/533,146
- Filed: 2026-02-07
- Published: 2026-08-13
- Earliest claimed: 2025-02-07
- Assignees: Northwestern University
- Applicants: Northwestern University
- Inventors: Nathan C. GIANNESCHI; Lauren M. IRIE; Dylan M. BROWN; Julius B. LUCKS
- Web page: https://patentgrep.com/patent/US20260232838A1

## CPC

- A61K 47/6933: {the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol}
- A61P 39/06: Free radical scavengers or antioxidants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are synthetic melanin nanoparticles and methods useful for protecting cell-free reactions from prolonged solar and UV exposure.

## Claims

### Claim 1

An additive, wherein the additive comprises a synthetic melanin nanoparticle, wherein the synthetic melanin nanoparticle comprises a synthetic melanin oligomer or a synthetic melanin polymer.

### Claim 2 (depends on 1)

The additive of claim 1, wherein the synthetic melanin oligomer or synthetic melanin polymer comprises a plurality of covalently-bonded melanin base units.

### Claim 3 (depends on 2)

The additive of claim 2, wherein the plurality of covalently-bonded melanin base units comprises a nitrogen-free precursor of allomelanin or an isomer thereof.

### Claim 4 (depends on 2)

The additive of claim 2, wherein the plurality of covalently-bonded melanin base units comprises 3,4-dihydroxydopamine monomer units, 3,4-dioxydopamine monomer units, 3,4-dihydroxynaphthalene monomer units, 1,3-dihydroxynapthalene monomer units, 1,4-dihydroxynapthalene monomer units, 1,5-dihydroxynapthalene monomer units, 1,6-dihydroxynapthalene monomer units, 1,7-dihydroxynapthalene monomer units, 1,8-dihydroxynapthalene monomer units, 2,3-dihydroxynapthalene monomer units, 2,6-dihydroxynapthalene monomer units, 2,7-dihydroxynapthalene monomer units, I-3,4-dihydroxyphenylalanine monomer units, catechol units, or any combination thereof.

### Claim 5 (depends on 2)

The additive of claim 2, wherein the plurality of covalently-bonded melanin base units comprises catechol units, 2,3-DHN monomer units, 2,6-DHN monomer units, 2.7-DHN monomer units, or any combination thereof.

### Claim 6 (depends on 2)

The additive of claim 2, wherein the plurality of covalently-bonded melanin base units comprises about a 1:1 molar ratio of 1,8-dihydroxynapthalene: 2,3-dihydroxynapthalene monomer units.

### Claim 7 (depends on 1)

The additive of claim 1, wherein the synthetic melanin oligomer or synthetic melanin polymer comprises a homopolymer or a copolymer.

### Claim 8 (depends on 7)

The additive of claim 7, wherein the homopolymer comprises a 2,3 DHN homopolymer or a 2,6-DHN homopolymer.

### Claim 9 (depends on 7)

The additive of claim 7, wherein the copolymer comprises two or more monomer units selected from the group consisting of: catechol, 2,7-DHN, 2,6-DHN, 2,3-DHN, and 1,8-DHN.

### Claim 10 (depends on 7)

The additive of claim 7, wherein the copolymer comprises catechol and 2,6-DHN monomer units.

### Claim 11 (depends on 10)

The additive of claim 10, wherein the copolymer comprises about 10-20 wt % of catechol monomer units and about 80-90 wt % of 2,6-DHN monomer units.

### Claim 12 (depends on 1)

A pharmaceutical composition comprising the additive of claim 1 and a pharmaceutically acceptable excipient.

### Claim 13 (depends on 1)

A method for protecting a cell-free reaction from damage, the method comprising contacting a cell-free reaction with the additive of claim 1.

### Claim 14

A method for protecting a cell-free reaction from damage, the method comprising contacting a cell-free reaction with an additive to generate a cell-free reaction mixture, wherein the additive comprises a synthetic melanin nanoparticle, wherein the synthetic melanin nanoparticle comprises a synthetic melanin oligomer or a synthetic melanin polymer.

### Claim 15 (depends on 14)

The method of claim 14, wherein the damage is at least partially caused by an exposure to solar light, ultraviolet (UV) irradiation, gamma irradiation, x-ray irradiation, or any combination thereof.

### Claim 16 (depends on 14)

The method of claim 14, wherein the cell-free reaction comprises a cell-free peptide synthesis reaction, a cell-free metabolic pathway reaction, a cell-free biosensor reaction, a cell-free gene expression system, an E. coli-based cell-free system, or any combination thereof.

### Claim 17 (depends on 14)

The method of claim 14, wherein the additive is present in the cell-free reaction at a concentration of between 0.25 mg/mL and 7.5 mg/mL, optionally between 0.25 mg/mL and 5 mg/mL, optionally between 0.25 mg/mL and 3 mg/mL, and/or optionally no greater than 3 mg/mL.

### Claim 18 (depends on 14)

The method of claim 14, wherein the method further comprises freeze-drying the cell-free reaction after contacting the cell-free reaction with the additive.

### Claim 19 (depends on 14)

The method of claim 14, wherein the synthetic melanin oligomer or polymer comprises a plurality of covalently-bonded melanin base units.

### Claim 20 (depends on 19)

The method of claim 19, wherein the plurality of covalently-bonded melanin base units comprises 3,4-dihydroxydopamine monomer units, 3,4-dioxydopamine monomer units, 3,4-dihydroxynaphthalene monomer units, 1,3-dihydroxynapthalene monomer units, 1,4-dihydroxynapthalene monomer units, 1,5-dihydroxynapthalene monomer units, 1,6-dihydroxynapthalene monomer units, 1,7-dihydroxynapthalene monomer units, 1,8-dihydroxynapthalene monomer units, 2,3-dihydroxynapthalene monomer units, 2,6-dihydroxynapthalene monomer units, 2,7-dihydroxynapthalene monomer units, I-3,4-dihydroxyphenylalanine monomer units, catechol units, or any combination thereof.
